Tolga Hassan
Chief Financial Officer @Agomab
Signup · Get unlimited contacts
WORK HISTORY
Chief Financial Officer @Agomab
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. The company raised around $240 million financing from top US and EU investors.
EDUCATION
Institute of Chartered Accountants in England and Wales
FCA
University of Cambridge
MA (Hons) Economics
London Business School
Executive Management
ABOUT TOLGA HASSAN
Strategic and versatile CFO with extensive experience in capital structuring, M&A, financial planning and corporate development in fast-moving biotech companies
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.